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Abstract
Endurance exercise has been shown to improve metabolic outcomes in obesity
and type 2 diabetes; however, the physiological and molecular mechanisms for
these benefits are not completely understood. Although endurance exercise
has been shown to decrease lipogenesis, promote fatty acid oxidation (FAO),
and increase mitochondrial biosynthesis in adipose tissue, muscle, and liver,
its effects on intestinal lipid metabolism remain unknown. The absorptive cells
of the small intestine, enterocytes, mediate the highly efficient absorption and
processing of nutrients, including dietary fat for delivery throughout the body.
We investigated how endurance exercise altered intestinal lipid metabolism in
obesity and type 2 diabetes using Otsuka Long-Evans Tokushima Fatty
(OLETF) rats. We assessed mRNA levels of genes associated with intestinal
lipid metabolism in nonhyperphagic, sedentary Long-Evans Tokushima
Otsuka (LETO) rats (L-Sed), hyperphagic, sedentary OLETF rats (O-Sed), and
endurance exercised OLETF rats (O-EndEx). O-Sed rats developed hyperphagia-induced obesity (HIO) and type 2 diabetes compared with L-Sed rats.
O-EndEx rats gained significantly less weight and fat pad mass, and had
improved serum metabolic parameters without change in food consumption
compared to O-Sed rats. Endurance exercise resulted in dramatic up-regulation of a number of genes in intestinal lipid metabolism and mitochondrial
content compared with sedentary rats. Overall, this study provides evidence
that endurance exercise programs intestinal lipid metabolism, likely contributing to its role in improving metabolic outcomes in obesity and type 2
diabetes.

Introduction
The obesity epidemic is associated with the overconsumption of energy-dense dietary fat, higher calorie
intake, and a sedentary lifestyle in developed countries
(Hedley et al. 2004; Cordain et al. 2005; Matthews et al.
2008). In addition, obesity increases the risk of developing other metabolic diseases including type 2 diabetes
mellitus, hepatic steatosis, and cardiovascular diseases
(Friedman 2002; Nikolopoulou and Kadoglou 2012).
Endurance exercise (EndEx) has been shown to improve

metabolic outcomes in obesity and type 2 diabetes in
human studies; however, the physiological and molecular
mechanisms for these benefits are not completely understood. The beneficial effects of EndEx include weight loss
(Cuff et al. 2003), improved insulin sensitivity and glucose metabolism (O’Hagan et al. 2013), ameliorated
postprandial triglyceridemic response (Merrill et al.
1989), and increased rate of fat oxidation (Bordenave
et al. 2008). However, it remains unclear how EndEx
training may affect lipid metabolism in the small
intestine.
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The small intestine mediates highly efficient absorption
and processing of dietary fat for delivery throughout the
body (Mansbach and Gorelick 2007). Once inside the enterocytes, the absorptive cells of the small intestine,
digested products of dietary fat are resynthesized into triacylglycerol (TAG), which are packaged in chylomicrons
(CMs) for secretion into lymph and then circulation or
are packaged in cytoplasmic lipid droplets (CLDs) (Zhu
et al. 2009; Uchida et al. 2012). The TAG that is, stored
in CLDs is cleared from the enterocytes after fasting,
likely the result of TAG secretion and/or fatty acid oxidation (FAO) within enterocytes. After a meal, TAG levels
in blood increase due to an increase in TAG secretion
from the small intestine and then decrease over time as a
result of clearance of TAG by peripheral tissues. This balance contributes to postprandial TAG levels and energy
distribution throughout the body.
The Otsuka Long-Evans Tokushima Fatty (OLETF) rat
is a commonly studied model of obesity and type 2 diabetes (Kawano et al. 1992) that has been used to investigate
the therapeutic effects of EndEx on obesity and type 2 diabetes. Selectively bred for deficiency in cholecystokinin-1
receptor, OLETF rats lack within-meal feedback for mediating satiety and exhibit hyperphagia-induced progressive
development of obesity, insulin resistance, and type 2 diabetes (Moran et al. 1998; Rector et al. 2010a). The therapeutic effects of EndEx on programming lipid metabolism
have been examined in many tissues in OLETF rats. In
contrast to hyperphagia-induced obesity (HIO), which
increases fat deposition in both adipose and ectopically in
nonadipose tissues, EndEx suppresses lipogenesis and promotes mitochondrial FAO in the liver (Rector et al. 2008)
and adipose tissue (Laye et al. 2009). However, lipogenesis
in skeletal muscle remains the same with EndEx (Rector
et al. 2010b). In addition, EndEx increases mitochondria
content in the liver (Rector et al. 2011), adipose tissue
(Laye et al. 2009), and skeletal muscle (Rector et al.
2010b), allowing more efficient FAO in response to the
large energy demand during exercise. A previous study in
OLETF rats demonstrated that HIO increased and EndEx
decreased TAG secretion from the small intestine (Hayashi
et al. 2002); however, how HIO and EndEx program intestinal lipid metabolism remains unclear.
Given that EndEx programs lipid metabolism in adipose, muscle, and liver and that the small intestine mediates processing dietary fat for systemic delivery and
modifies the risk of development of obesity and diabetes,
we hypothesized that EndEx programs intestinal lipid
metabolism that is dysregulated in HIO to reduce obesity
and type 2 diabetes. To determine the effects of EndEx
on intestinal lipid metabolism, we assessed the mRNA
levels of genes associated with intestinal lipid metabolism
in control, nonhyperphagic, sedentary Long-Evans
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Tokushima Otsuka (LETO) rats (L-Sed), hyperphagic,
sedentary OLETF rats (O-Sed), and EndEx trained OLETF
rats (O-EndEx). Although levels of the proteins and their
function in intestinal lipid metabolism are ultimately
essential for confirming the effects of exercise on intestinal lipid metabolism, mRNA levels have been previously
associated with functional changes in intestinal lipid
metabolism (van Schothorst et al. 2009; Uchida et al.
2011; Kimura et al. 2013).

Materials and Methods
Animals and experimental design
Male LETO and OLETF rats were obtained at 4 weeks of
age (Tokushima Research Institute, Otsuka Pharmaceutical, Tokushima, Japan). Animals were individually housed
in a temperature-controlled (21°C) environment with
0600–1800 h light and 1800–0600 h dark cycles. All
groups had ad libitum access to water and standard chow
which was composed of 56% carbohydrate, 17% fat, and
27% protein (Formulab 5008; Purina Mills, St Louis,
MO). The rats were assigned to three groups (n = 6–8
rats in each group): 1) sedentary LETO (L-Sed), 2) sedentary OLETF (O-Sed) and 3) EndEx OLETF (O-EndEx).
L-Sed rats were used as healthy, nonhyperphagic controls
and O-Sed rats were hyperphagic and developed obesity
and type 2 diabetes. At 19 weeks of age, all OLETF rats
were exposed to treadmill running at 15 m/min for
5 min/day to allow for acclimation to the running stimulus. OLETF rats were then randomly assigned to O-Sed
or O-EndEx. Treatments began at 20 weeks of age,
because it has previously documented that the OLETF rat
becomes hyperglycemic and hyperinsulinemic at this age
(Bunker et al. 2010; Rector et al. 2010a). EndEx training
initially consisted of treadmill running at a speed of
15 m/min on a 15% incline for 5 min/day. Duration and
speed were gradually increased by 2–3 min/day and 1–
2 m/min per week such that by week 4 the animals were
running at a speed of 20 m/min on a 15% incline for
60 min/day, 5 days/week and this intensity was maintained for the duration of the treatment. Exercise training
lasted 12 weeks and all the animals were killed at age
32 weeks. The last exercise bout was performed 18 h
prior to euthanasia. Food was removed from the cages
12 h prior to death, and water was removed on the
morning of the experiment 1 h prior to euthanasia. All
protocols were approved by the University of Missouri
Animal Care and Use Committee. The animals were killed
by exsanguination and intestinal mucosa and blood were
then collected. The small intestine was divided into six
equal length segments and labeled S1–S6 (proximal to
distal) in relation to the stomach. S1 represented the
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duodenum and S2 represents upper jejunum (Uchida
et al. 2013).

Body weight, body composition, and food
intake
Body weights and food intakes were monitored and
recorded on a weekly basis. Body composition was
assessed by dual-energy X-ray absorptiometry (DXA;
Hologic QDR-1000, Bedford, MA; calibrated for rodents)
on the day of death. Omental, retroperitoneal, and
epididymal fat pads were collected and weighed.

Blood parameters
Whole blood was collected on the day of euthanasia and
serum samples were prepared by centrifugation and
stored at 80°C until analysis. Glucose and TAG assays
were performed by a commercial laboratory (Comparative
Clinical Pathology Services, Columbia, MO) on an Olympus AU680 automated chemistry analyzer (BeckmanCoulter, Brea, CA) using commercially available assays
according to manufacturers’ guidelines. Plasma insulin
concentrations were determined using a commercially
available, rat-specific enzyme-linked immunosorbent assay
(Alpco Diagnostics, Salem, NH). Samples were run in
duplicate and manufacturers’ controls and calibrators
were used according to assay instructions.

RNA extraction and cDNA synthesis
Total RNA was extracted from S2 of intestinal mucosa
using RNA Stat-60 (Tel-Test, Friendswood, TX). The
RNA was quantified using NanoDrop ND-1000 (Thermo
Fischer Scientific, Wilmington, DE) then DNase treated
with TurboDNA-free (Ambion, Austin, TX). cDNA was
synthesized from 1 lg Dnase treated RNA by Affinity
Script QPCR cDNA using oligo dT and random hexamer
primers (Stratagene, LaJolla, CA).

q-PCR measurement
SYBR green q-PCR was performed using Mx3000P QPCR
System (Stratagene) and Brilliant II and III SYBR green
mastermix (Stratagene). Primers were produced by Integrated DNA technologies (Coralville, IA) and designed to
generate PCR products between 100 and 400 base pairs.
Primers used for this study are as shown in Table 1. The
genes that were examined include acetyl-CoA carboxylase
1 (Acc1), acyl-CoA synthetase 5 (Acsl5), acyl-CoA oxidase
(Acox), adipose triglyceride lipase (Atgl), fatty acid
translocase (Cd36), carnitine palmitoyltransferase I (Cpt1),
diacylglycerol-O-acyltransferase 1 (Dgat1), diacylglycerolO-acyltransferase 2 (Dgat2), hormone-sensitive lipase
(Hsl), liver X receptor a (Lxra), medium-chain acylcoenzyme A dehydrogenase (Mcad), monoacylglycerol-Oacyltransferase 2 (Mgat2), microsomal triglyceride transfer

Table 1. Primers used for q-PCR.
Gene
18S
Acsl5
Acc1
Atgl
Acox
Cd36
Cpt1
Dgat1
Dgat2
Hsl
Lxra
Mtp
Mgat2
Mcad
Plin2
Plin3
Pgc1a
Ppara
Srebp1c
Tfam
Ucp2

Forward

Reverse

50 -TTAGAGTGTTCAAAGCAGGCCCGA-30
50 -CTGACACCGACACTGAAAG-30
50 -CGGTCACACTTCACTCTATG-30
50 -GAACCGAAAGACCTGATGAC-30
50 -AAGCTTCGTGCAGCCAGATTGGTA-30
50 -ACGACTGCAGGTCAACATACTGGT-30
50 -GGCTCAAGCTGTTCAAGATA-30
50 -ACTGGTGGAATGCTGAGTCTGTCA-30
50 -CAAGAAGTTCCCTGGCATAA-30
50 -CACAAGCACTACTGGGATAC-30
50 -ATCGTGTCCGTGCAGGAGATTGTT-30
50 -TCAGGTGCTGGGTGTCACTTCAAA-30
50 -GAGGTTCCGCATCTACAAAC-30
50 -GGCCTTTGCTGGAGATATT-30
50 -GAGTCCCTGTCTACCAAGAT-30
50 -GTGGGACAGATGGTGATTAG -30
50 -AGTACAACAATGAGCCCGCGAACA-30
50 -AGATCGGCCTGGCCTTCTAAACAT-30
50 -GGAGCCATGGATTGCACATTTG-30
50 -GCTGATGGGCTTAGAGAAGGAAG-30
50 -AAGCAGTTCTACACCAAGGGCTCA-30

50 -TCTTGGCAAATGCTTTCGCTCTGG-30
50 -GACTGAAGTCCAAGGAGAAAG-30
50 -CGGTCCTCCTCAAACTTATC -30
50 -GAAATTGGGTGACCATCTACC-30
50 -AAGGCATCCACCAGAGCAACA-30
50 -TGGTCCCAGTCTCATTTAGCCACA-30
50 -CTCCATGGCTCAGACAATAC-30
50 -ACAGCTGCATTGCCATAGTTCCCT-30
50 -GTATACCTCATTCTCTCCAAAGG-30
50 -GTATCTTCTTCCGTGCCAG-30
50 -TTAATGAACTCCACCTGCAGCCCT-30
50 -ATTACTCCTGCCACTTGCTTCCCA-30
50 -GCCGTCTTTATCGACATTCC-’3
50 -CGTAGTTACATGAGGGTGAAG-30
50 -CAGAGAGCTTGTCCTGAATTT-30
50 -CACTCTGCCTGACATTACAC-30
50 -TGGCAGGGTTTGTTCTGATCCTGT-30
50 -TGTGCAAATCCCTGCTCTCCTGTA-30
50 -GCTTCCAGAGAGGAGCCCAG-30
50 -TGCTGACCGAGGTCTTTTTGG-30
50 -AATGGCATTTCGGGCAACATTGGG-30
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protein (Mtp), perilipin 2 (Plin2), perilipin 3 (Plin3), peroxisome proliferator-activated receptor a (Ppara), PPAR-c
coactivator-1 a (Pgc1a), sterol regulatory element-binding
protein 1 (Srebp1c), mitochondria transcription factor A
(Tfam), and uncoupling protein 2 (Ucp2). Each primer was
validated for producing a single product of the correct size
and amplifying product with efficiency between 80 and
120%. Analysis of the melting curve confirmed the production of a single product and post-PCR products were subjected to 1.5% agarose gel electrophoresis for ensuring a
single product and that the product size was correct. The
mRNA level of each gene was normalized to18S mRNA levels and calculated with the comparative CT method using
L-Sed as the reference group. In addition, there is no significant difference in CT values of 18S among experimental
groups.

Statistics
One-way analysis of variance (ANOVA) was used to test
for differences among groups in body weight, food intake,
percent body fat, fat pad weight, blood parameters, and
mRNA levels of genes examined in this study. Statistical
analyses of data were performed in SAS (SAS Institute,
Inc., Cary, NC). A significant main effect (P < 0.05) was
followed-up with Tukey multiple group comparison. Values are reported as means  standard error of the mean
(SEM), and a P value < 0.05 denotes a statistically significant difference.

Results
EndEx decreases body weight and improves
body composition in OLETF rats
Consistent with our previous reports (Rector et al. 2008,
2011; Linden et al. 2014), O-Sed rats developed obesity
due to hyperphagia compared with L-Sed rats and
O-EndEx rats had lower body weight (P < 0.05; Fig. 1A)
and favored body composition (P < 0.05; Fig. 1B and C)
compared with O-Sed rats. O-Sed and O-EndEx had significantly greater weekly food consumptions than L-Sed
rats (P < 0.05; Fig. 1D), with O-Sed and O-EndEx rats
having similar calorie intake from 20 to 32 weeks of age
(Fig. 1D).

EndEx improves serum parameters in OLETF
rats
EndEx training improved fasting glucose compared with
O-Sed (P < 0.05; Fig. 1E); however, fasting glucose levels
did not return to those observed in L-Sed. Similarly,
EndEx partially attenuated serum TAG compared with
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O-Sed rats (P < 0.05; Fig. 1G). There was no significant
difference in the levels of fasting plasma insulin among
the groups (Fig. 1F), likely due to the variability in pancreatic b-cell dysfunction and disease progression
observed in the O-Sed rats.

EndEx increases mRNA levels for markers of
enterocyte lipid anabolism
Relative mRNA levels for genes associated with lipid
anabolism including CM synthesis and secretion (Mtp
and Cd36), CLD formation (Plin2 and Plin3), and fatty
acid and TAG synthesis (Dgat1, Dgat2, Mgat2, Srebp1c,
Lxra, Acc1, and Acsl5) were determined in intestinal
mucosa. O-Sed rats had higher mRNA levels of Mtp and
Cd36 compared with L-Sed rats (P < 0.05; Fig. 2A),
which were further increased in O-EndEx rats (P < 0.05;
Fig. 2A). While O-Sed rats had higher mRNA level of
Plin2, a gene involved in CLD formation, than L-Sed rats,
O-EndEx rats had even greater mRNA levels of Plin2 and
Plin3 compared with L-Sed rats and O-Sed rats (P < 0.05;
Fig. 2B). O-Sed rats had similar mRNA levels for genes in
TAG and fatty acid synthesis compared with L-Sed rats;
however, O-EndEx rats had greater mRNA levels in TAG
and fatty acid synthesis genes, including Dgat2, Lxra,
Acc1, and Acsl5 compared with L-Sed and O-Sed rats
(P < 0.05; Fig. 2B). In addition, O-EndEx rats had higher
mRNA levels of Dgat1 and Mgat2 compared with L-Sed
rats (P < 0.05; Fig. 2B). There was no significant difference in mRNA level of Srebp1c among the groups
(Fig. 2B).

EndEx increases mRNA levels for markers of
enterocyte lipid catabolism and
mitochondrial content
Gene expression of markers related to catabolic metabolism of TAG and fatty acids including lipolysis (Hsl and
Atgl) and FAO (Ppara, Pgc1a, Acox, Cpt1a, Ucp2, and
Mcad) and mitochondrial content (Tfam) were determined in intestinal mucosa. O-Sed and L-Sed rats had
similar mRNA levels of Hsl and Atgl (Fig. 3A); whereas,
EndEx increased these lipolytic genes (P < 0.05; Fig. 3A).
O-Sed rats had higher mRNA level of Ucp2 compared
with L-Sed rats; however, O-EndEx rats had higher
mRNA levels in genes related to FAO including Ppara,
Acox, Cpt1, and Ucp2 compared with L-Sed and O-Sed
rats (P < 0.05; Fig. 3B). O-EndEx rats also had higher
mRNA levels of Pgc1a and Mcad compared with L-Sed
rats only (P < 0.05; Fig. 3B), and EndEx significantly
increased mRNA levels of Tfam, a marker of mitochondrial content, compared with L-Sed and O-Sed (P < 0.05;
Fig. 3C).
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Figure 1. Endurance exercise improves metabolic outcomes in hyperphagic, obese rats. Body weight (A), fat pad mass (B, sum of omental,
retroperitoneal, and epididymal pad), and % of body fat (C) were determined at the end of the study. Weekly food intakes (D) were averaged
across the period of the intervention (age 20–32 weeks). Levels of fasting blood glucose (E), insulin (F) and triacylglycerol, TAG (G) were
determined at the end of the study. Values are means  SEM (n = 6–8 rats/group). In (F), ♦ = L-Sed rats; ■ = O-Sed rats; ▲ = O-EndEx rats.
Bars with different letters are significant (P < 0.05).

Discussion
Here, we demonstrate that EndEx training significantly
alters mRNA levels for genes involved intestinal lipid
metabolism. While HIO increased intestinal mRNA levels
of lipid metabolism genes, including Mtp, Cd36, Plin2,
and Ucp2, in O-Sed compared to L-Sed rats, EndEx training robustly increased mRNA levels of even more genes
involved in intestinal lipid anabolism and catabolism as
well as mitochondrial content/function/biogenesis, including Plins, Dgat2, Acc1, Ppara, Cpt1, Acox, and Tfam.
These findings suggest potential for enhanced lipid
turnover and more efficient FAO for energy utilization
within enterocytes with EndEx. Overall, this study provides evidence that EndEx programs intestinal lipid
metabolism, likely contributing to its role in improving
metabolic outcomes in obesity and type 2 diabetes.
EndEx was previously found to reverse elevated lymphatic lipid transport found in OLETF rats (Hayashi et al.

2002). Because of this, we hypothesized that changes in
the intestine in response to EndEx may limit substrates
for TAG synthesis and secretion on CMs. In fact, previous
studies found that EndEx increases FAO in tissues including muscle, liver, and adipose (Laye et al. 2009; Rector
et al. 2010b, 2011), and this increase in FAO activity is
accompanied by higher mRNA levels of genes associated
with FAO and/or increased mitochondrial content and
function. Consistent with these findings, the intestine of
O-EndEx rats had remarkably higher mRNA levels of
Ppara and its downstream targets Acox, Cpt1, and Ucp2,
compared to O-Sed rats. Although activity of intestinal
FAO is considered low, PPARa is highly expressed in the
small intestine (Bunger et al. 2007; de Vogel-van den Bosch et al. 2008) and PPARa-mediated FAO in enterocytes
has previously been shown to reduce the postprandial triglyceridemic response by limiting substrates for TAG synthesis and secretion in CMs (Kimura et al. 2011, 2013;
Uchida et al. 2011). Additionally, O-EndEx rats had
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remarkably higher mRNA level of Tfam, which was
reported to directly correlate with mitochondrial DNA
content (Ekstrand et al. 2004). Unexpectedly, O-EndEx
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rats had increased mRNA levels of Cd36 and Mtp, genes
typically associated with CM synthesis and secretion,
compared with O-Sed and L-Sed rats. It remains unclear
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why these genes may be elevated; however, these genes
may also play roles in other metabolic pathways within
enterocytes independent of CM synthesis and secretion.
Taken together, our finding suggests that EndEx may
increase FAO in the small intestine and contribute to the
previously reported reduced postprandial triglyceridemic
response (Hayashi et al. 2002). Future studies are necessary to determine whether the changes observed in mRNA
levels in these processes translate to physiological changes
in FAO in the small intestine.
Surprisingly, while O-EndEx rats had higher intestinal
mRNA levels of genes involved intestinal catabolism
(lipolysis and FAO), they also had higher intestinal
mRNA levels of genes involved in intestinal anabolism
(CLD formation, TAG synthesis, and fatty acid synthesis)
compared with O-Sed rats. These findings differ from
those previously observed in the liver and adipose tissue
of these animals (Rector et al. 2008, 2010b; Laye et al.
2009); however, similar findings have been observed in
skeletal muscle with exercise training (Goodpaster et al.
2001; Koves et al. 2013). In skeletal muscle, parallel activation in lipid anabolism and catabolism suggests that
intramuscular CLDs are able to provide a rapid, local
energy source in response to exercise. Based on our findings related to intestinal lipid metabolism and mitochondrial content, EndEx may provide similar adaptations by
programming intestinal lipid metabolism to be more efficient under certain conditions. In fact, the small intestine
accounts for 25% of total body oxygen consumption (Yen
et al. 1989; Vaugelade et al. 1994), reflecting the substantial energy demand by the intestine for nutrient processing and other basic cellular functions. Although glutamine
is considered the major fuel source for enterocytes (Windmueller and Spaeth 1980), it has also been demonstrated
that enterocytes oxidize fatty acids during lipid absorption
(Gangl and Ockner 1975). It is possible that more efficient
lipid metabolism within enterocytes may provide an efficient/extra energy source to process overloaded nutrients
and limit TAG secretion from the intestine in obesity and
type 2 diabetes, contributing to the hypotriglyceridemic
effect of EndEx seen in other studies (Merrill et al. 1989;
Hardman 1998; Davitt et al. 2013). In addition, the efficient/extra energy source produced from lipid metabolism
within enterocytes may be required for EndEx to carry
out other beneficial functions on small intestine to
improve obesity and diabetes such as enhancing the
release of glucagon-like peptide 1 (GLP-1; Allen et al.
2012) and cholesterol efflux (Khabazian et al. 2009).
The mechanism for how EndEx may alter intestinal
lipid metabolism is not clear and needs to be identified in
future studies. The EndEx-induced changes in intestinal
lipid metabolism could be secondary or due to crosstalk
between tissues that are modified by EndEx. For example,
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EndEx was reported to alter metabolism of thyroid hormone and leptin in rats (Story and Griffith 1974; Uribe
et al. 2014). Both thyroid hormone and leptin have been
demonstrated to have effects on lipid metabolism in other
tissues and have receptors and signaling present in the
small intestine. In addition, IL-6, a factor released from
exercise trained muscle, enhances the release of GLP-1 by
the intestine which contributes to improved glycemia
under obesity and diabetes (Pedersen et al. 2004; Allen
et al. 2012). Recently, emerging evidence also shows that
exercise training can modify the composition of gut microbiota and have beneficial effects to improve obesity
(Evans et al. 2014; Petriz et al. 2014). Each of these examples may serve as potential mechanisms of EndEx-induced
changes in intestinal lipid metabolism.
The effect of obesity and type 2 diabetes on intestinal
lipid metabolism has been investigated in a variety of
models including, high fat feeding, high fat/fructose/cholesterol feeding, and genetic models, such as leptin-deficiency (Naples et al. 2012; Uchida et al. 2012), however,
little is known about the effects of hyperphagia-induced
obesity and type 2 diabetes on intestinal lipid metabolism.
Here, HIO increased intestinal mRNA levels of genes
involved in CM synthesis and secretion (Cd36 and Mtp)
but not in genes involved in TAG and fatty acid synthesis.
Higher levels of Cd36 and Mtp are consistent with greater
lymphatic lipid secretion previously reported in the
OLETF rat model of HIO (Hayashi et al. 2002). Multiple
genes involved in TAG synthesis (Mgat2 and Dgat2) and
FAO (Acox, Cpt1, Ppara) have been shown to be elevated
in high-fat-diet fed, obese, compared with low fat fed,
lean mice (de Wit et al. 2008; Uchida et al. 2012),
whereas, in the current report O-Sed rats fed standard
chow only had higher level of one gene in FAO, Ucp2, in
enterocytes compared with L-Sed rats. This suggests that
intestinal genes involved in TAG synthesis and FAO may
be less sensitive to the metabolic changes in obesity than
to changes in diet composition. In addition, the pool of
TAG stored in CLD is a possible source of lipid contributing to CM synthesis and secretion. In this study, O-Sed
rats had higher intestinal Plin2, a CLD associated protein
associated with large CLDs in enterocytes (Lee et al.
2009) and cellular TAG content, compared with L-SED
rats.
Overall, our study provides novel evidence that HIO
and EndEx program intestinal lipid metabolism in OLETF
rats. This is the first study demonstrating that EndEx
training increases mRNA expression of genes involved in
intestinal lipid anabolism and catabolism as well as mitochondrial biogenesis/content within enterocytes. We propose that the exercise-induced changes in lipid
metabolism and mitochondria biogenesis allow more efficient FAO in enterocytes and this altered lipid metabo-
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lism may contribute to the therapeutic effects of exercise
training on treating obesity and type 2 diabetes. In addition, we found that the magnitude of changes in mRNA
expression in enterocytes is much larger than previously
identified changes in other tissues involved in lipid
metabolism in response to EndEx (Rector et al. 2010b;
Yasari et al. 2010), highlighting the potential importance
of exercise-induced alterations in intestinal lipid metabolism. Future studies are required to know if the changes
in gene expression involved in intestinal lipid metabolism
reflect significantly physiological performance and to
investigate the molecular mechanism of EndEx regulating
intestinal lipid metabolism.
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